Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

The impact of Vincristine induced neuropathy on sensorimotor function in children diagnosed with cancer.

EF 2012-13

Résumé
Advances in multimodal management, including chemotherapy, in pediatric oncology patients has increased survival rates to over 80%. Children diagnosed with leukaemia often receive vincristine, a chemotherapeutic agent, during their treatment. Despite vincristine's efficacy, it is a documented neurotoxin resulting in nerve damage with consequences for sensory and motor function. Recent studies in children with acute lymphoblastic leukaemia (ALL) have shown that in addition to nerve damage, there is evidence of damage to white matter in the brain following treatment. However, children with ALL also receive the drug methotrexate which is known to cause leukoencephalopathy. Currently, no publications examine the effect of vincristine alone on white matter and how this relates to motor and sensory performance. In children, whose brains are still developing, damage may have long-term impact on balance and coordination, and may negatively impact quality of life (QOL). This pilot project will evaluate the impact of vincristine on white matter integrity in the brain through diffusion tensor imaging, an advanced MRI technique. If the pilot results suggest children with vincristine neuropathy show changes in white matter integrity that are associated with impairments in sensory-motor function, it will be the first study to demonstrate this association. Positive findings from this study will form the basis of an operating grant application submitted to CIHR by N. Virji-Babul, A. Rankin, R. Rassekh and J. Hukin, that aims to 1. evaluate long-term impact of vincristine on sensory-motor function and white matter integrity 2. identify genetic risk factors for developing neuropathy and 3. evaluate effectiveness of physical therapy interventions to minimize the effects of neuropathy. As prognosis improves in childhood cancers, understanding chemotherapy-induced changes in the brain will help develop more appropriate therapeutics with fewer side effects and improve QOL.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
280784
Name
Smith Jenna R
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Clinical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
The impact of Vincristine induced neuropathy on sensorimotor function in children diagnosed with cancer.
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Acute Lymphoblastic Leukaemia; Cancer; Chemotherapy; Diffusion Tensor Imaging; Leukaemia; Neuroimaging; Neuropathy; Pediatrics; Vincristine; White Matter
Abstract
Advances in multimodal management, including chemotherapy, in pediatric oncology patients has increased survival rates to over 80%. Children diagnosed with leukaemia often receive vincristine, a chemotherapeutic agent, during their treatment. Despite vincristine's efficacy, it is a documented neurotoxin resulting in nerve damage with consequences for sensory and motor function. Recent studies in children with acute lymphoblastic leukaemia (ALL) have shown that in addition to nerve damage, there is evidence of damage to white matter in the brain following treatment. However, children with ALL also receive the drug methotrexate which is known to cause leukoencephalopathy. Currently, no publications examine the effect of vincristine alone on white matter and how this relates to motor and sensory performance. In children, whose brains are still developing, damage may have long-term impact on balance and coordination, and may negatively impact quality of life (QOL). This pilot project will evaluate the impact of vincristine on white matter integrity in the brain through diffusion tensor imaging, an advanced MRI technique. If the pilot results suggest children with vincristine neuropathy show changes in white matter integrity that are associated with impairments in sensory-motor function, it will be the first study to demonstrate this association. Positive findings from this study will form the basis of an operating grant application submitted to CIHR by N. Virji-Babul, A. Rankin, R. Rassekh and J. Hukin, that aims to 1. evaluate long-term impact of vincristine on sensory-motor function and white matter integrity 2. identify genetic risk factors for developing neuropathy and 3. evaluate effectiveness of physical therapy interventions to minimize the effects of neuropathy. As prognosis improves in childhood cancers, understanding chemotherapy-induced changes in the brain will help develop more appropriate therapeutics with fewer side effects and improve QOL.
Competitiondate
201302
Approvedterm2
1 yr 0 mth
Pinamesdelim
Smith, Jenna R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~